poisar

News

Current market catalysts

Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.

Latest Coverage

Latest Headlines

30 headlines

  1. SEC EDGARSEC EDGAR

    8-K filing — Federal Home Loan Bank of Boston

    Filed: 2026-09-08 AccNo: 0001331463-26-000174 Size: 164 KB Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

  2. SEC EDGARSEC EDGAR

    8-K filing — FRANKLIN ELECTRIC CO INC (FELE)

    Filed: 2026-09-08 AccNo: 0000038725-26-000062 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

  3. SEC EDGARSEC EDGAR

    8-K filing — Exascale Labs Holdings Inc. (XLABW)

    Filed: 2026-09-08 AccNo: 0001829126-26-009860 Size: 245 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

  4. SEC EDGARSEC EDGAR

    8-K filing — Laser Photonics Corp (LASE)

    Filed: 2026-09-08 AccNo: 0001493152-26-041734 Size: 200 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

  5. Zacks Investment ResearchNa

    3 Insurers to Watch as Competition in Personal Auto Intensifies

    The U.S. personal auto insurance industry is transitioning from a rate-increase phase to competitive growth as loss ratios improve. Leading insurers with superior underwriting, technology, and distribution capabilities are positioned to gain market share and sustain profitability. The Travelers, Allstate, and Progressive are well-positioned to benefit from this shift, though competitive pricing may moderate industry-wide returns.

  6. Zacks Investment ResearchNa

    Verastem Stock Skyrockets 121% in 3 Months: Here Is Why

    Verastem (VSTM) shares have surged 121% over three months, driven by accelerating sales of ovarian cancer drug Avmapki Fakzynja Co-Pack, which generated $25.1 million in Q2 2026 revenues (up 1,095% YoY), and growing optimism around VS-7375, a KRAS G12D inhibitor in phase II trials across pancreatic, lung, and colorectal cancers. The company expects VS-7375 data in October 2026 and plans FDA meetings before year-end to discuss phase III pivotal trial designs.

  7. Zacks Investment ResearchZacks Equity Research

    The Zacks Analyst Blog Highlights FANUY, ABBNY, KYCCF, NVDA, ISRG, ILMN, NOVT, BOTZ, ROBO, ROBT and IBOT

    Zacks highlights the robotics and AI sector as a major growth opportunity, with the general-purpose robotics market projected to grow from under $1 billion in 2025 to $370 billion by 2040. The article examines key industry players including Fanuc, ABB, Keyence, NVIDIA, Intuitive Surgical, and Illumina, and recommends four robotics-focused ETFs (BOTZ, ROBO, ROBT, IBOT) as diversified investment vehicles to capitalize on this trend.

Source
Source-attributed market-news archive
Observed
Checked
Cadence
Continuous captured-news feed
Status
fresh